Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKCOM Regulatory News (KCOM)

  • There is currently no data for KCOM

Form 8 (OPD) (KCOM Group PLC)

3 May 2019 14:18

RNS Number : 0763Y
KCOM Group PLC
03 May 2019
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

KCOM GROUP PUBLIC LIMITED COMPANY ("KCOM")

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

 

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

KCOM

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

1 MAY 2019

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

 

N/A

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares in KCOM

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

NIL

NIL

(2) Cash-settled derivatives:

 

NIL

NIL

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

NIL

NIL

 

TOTAL:

NIL

NIL

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

NONE

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(a) Ordinary shares in KCOM owned by KCOM directors

 

Name

Number of ordinary shares in KCOM

Percentage of issued ordinary share capital in KCOM (per cent)(1)

Graham Sutherland

250,000

0.04839

Anna Bielby

17,016

0.00330

Peter Smith

50,000

0.00968

 

(1) Rounded to 5 decimal places

 

(b) Long Term Incentive Plan ("LTIP") awards held by KCOM executive directors

 

(i) LTIP award (in the form of an option in respect of KCOM ordinary shares) held by Graham Sutherland

 

Grant Date

Vesting Date

 

Exercise Price (£)

 

Outstanding

30 November 2018

29 November 2021

0.00

872,340

 

 

(ii) LTIP awards (in the form of options in respect of KCOM ordinary shares) held by Anna Bielby

 

Grant Date

Vesting Date

Exercise Price

(£)

 

Outstanding

15 February 2019

14 February 2022

0.00

 

404,494

11 July 2018

10 July 2021

0.00

75,078

7 July 2017

6 July 2020

0.00

29,050

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

3 May 2019

Contact name:

Sally Jones

Group Company Secretary

Telephone number:

01482 602595

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEESSMFDDFUSEFI
Date   Source Headline
1st Jul 201510:17 amRNSAnnual Financial Report
12th Jun 201511:47 amRNSDirector/PDMR Shareholding
5th Jun 20157:00 amRNSFinal Results
1st Jun 20152:26 pmRNSDirector Declaration
20th May 20154:02 pmRNSAppointment-Joint Financial Adviser & Joint Broker
12th May 20155:10 pmRNSDirector/PDMR Shareholding
13th Apr 20154:43 pmRNSDirector/PDMR Shareholding
7th Apr 201510:02 amRNSDirectorate Change
1st Apr 20155:38 pmRNSHolding(s) in Company
26th Mar 20153:30 pmRNSEmployee Benefit Trust Dealing
26th Mar 20157:00 amRNSPre-close Statement
16th Mar 201510:06 amRNSDirector/PDMR Shareholding
13th Feb 201511:14 amRNSDirector/PDMR Shareholding
5th Feb 20154:01 pmRNSDirector/PDMR Shareholding
2nd Feb 20159:56 amRNSBlocklisting Interim Review
13th Jan 20159:32 amRNSDirector/PDMR Shareholding
5th Jan 201510:22 amRNSDirector Appointment
15th Dec 20148:56 amRNSDirector/PDMR Shareholding
25th Nov 20147:00 amRNSHalf Yearly Report
19th Nov 201411:27 amRNSEmployee Benefit Trust Dealing
12th Nov 20141:26 pmRNSDirector/PDMR Shareholding
13th Oct 20144:45 pmRNSDirector/PDMR Shareholding
30th Sep 20147:00 amRNSPre-close Statement
11th Sep 20143:55 pmRNSDirector/PDMR Shareholding
11th Aug 20145:08 pmRNSDirector/PDMR Shareholding
7th Aug 20144:07 pmRNSDirector/PDMR Shareholding
1st Aug 20149:03 amRNSBlocklisting Interim Review
31st Jul 20142:42 pmRNSDirector/PDMR Shareholding
31st Jul 20142:41 pmRNSDirector/PDMR Shareholding
29th Jul 20143:03 pmRNSDirector/PDMR Shareholding
29th Jul 20142:01 pmRNSResult of AGM
29th Jul 201412:37 pmRNSRetirement of Director
29th Jul 20147:00 amRNSInterim Management Statement
18th Jul 201411:38 amRNSDirector/PDMR Shareholding
16th Jul 20144:47 pmRNSEmployee Benefit Trust Dealing
14th Jul 20142:01 pmRNSDirector/PDMR Shareholding
10th Jul 20144:33 pmRNSAnnual Financial Report
16th Jun 20145:13 pmRNSEmployee Benefit Trust Dealing
13th Jun 201412:07 pmRNSDirector/PDMR Shareholding
6th Jun 20147:00 amRNSFinal Results
14th May 20147:00 amRNSDirector/PDMR Shareholding
14th Apr 20149:59 amRNSDirector/PDMR Shareholding
25th Mar 20147:00 amRNSPre-close statement
17th Mar 201411:57 amRNSHolding(s) in Company
12th Mar 20144:36 pmRNSDirector/PDMR Shareholding
12th Feb 20149:56 amRNSDirector/PDMR Shareholding
10th Feb 20143:56 pmRNSDirector/PDMR Shareholding
5th Feb 20149:35 amRNSDirector Declaration
3rd Feb 20147:00 amRNSBlocklisting Interim Review
31st Jan 20143:23 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.